Marshall Wace LLP purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 41,563 shares of the company’s stock, valued at approximately $5,672,000.
A number of other institutional investors have also recently bought and sold shares of the stock. Xponance Inc. raised its holdings in shares of Clorox by 0.6% during the second quarter. Xponance Inc. now owns 28,451 shares of the company’s stock valued at $3,883,000 after acquiring an additional 181 shares during the period. Public Sector Pension Investment Board raised its stake in Clorox by 75.6% during the 2nd quarter. Public Sector Pension Investment Board now owns 4,775 shares of the company’s stock valued at $652,000 after purchasing an additional 2,055 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Clorox by 134.9% in the second quarter. EverSource Wealth Advisors LLC now owns 2,699 shares of the company’s stock valued at $356,000 after purchasing an additional 1,550 shares in the last quarter. Ensign Peak Advisors Inc boosted its position in shares of Clorox by 0.8% in the second quarter. Ensign Peak Advisors Inc now owns 109,280 shares of the company’s stock worth $14,913,000 after buying an additional 826 shares during the period. Finally, Westwood Holdings Group Inc. grew its holdings in shares of Clorox by 2.2% during the second quarter. Westwood Holdings Group Inc. now owns 12,169 shares of the company’s stock valued at $1,661,000 after buying an additional 264 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
Shares of NYSE:CLX opened at $162.90 on Tuesday. The firm has a market capitalization of $20.23 billion, a PE ratio of 84.40, a PEG ratio of 3.31 and a beta of 0.40. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09. The business’s 50 day moving average is $152.52 and its 200-day moving average is $144.04.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is 252.85%.
Analyst Upgrades and Downgrades
CLX has been the subject of several research analyst reports. Citigroup raised their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Wells Fargo & Company decreased their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. DA Davidson restated a “neutral” rating and set a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Finally, BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Six analysts have rated the stock with a sell rating and twelve have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $143.33.
Read Our Latest Stock Report on CLX
Insider Buying and Selling at Clorox
In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.51% of the company’s stock.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- What to Know About Investing in Penny Stocks
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How to Invest in Small Cap Stocks
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- ESG Stocks, What Investors Should Know
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.